Judicialização de produtos à base de canabidiol no Brasil: uma análise de 2019 a 2022 [PDF]
Cadernos De Saude Publica, 2023 Este estudo analisou as ações judiciais de pacientes que solicitaram ao Sistema Único de Saúde produtos à base de canabidiol (CBD) durante o período de 2019 a 2022, descrevendo características sociodemográficas, clínicas e jurídicas.
Ronaldo Portela +6 more
exaly +4 more sources
Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD) Desempenho de pacientes esquizofrênicos no Stroop Color Word Test e responsividade eletrodérmica após administração aguda de canabidiol (CBD) [PDF]
Brazilian Journal of Psychiatry, 2010 OBJECTIVE: The last decade has seen increasing evidence of dysfunctions in the endogenous cannabinoid system in schizophrenia and of its relationship with the typical cognitive impairment of the disorder. Studies in animal models, healthy volunteers, and
Jaime E. C. Hallak +8 more
doaj +4 more sources
My child is growing and now? Exploring the environmental needs of children with congenital Zika syndrome according to their caregivers' perceptions. [PDF]
Health Expect, 2022 Abstract Introduction Promoting social inclusion of children with congenital Zika virus syndrome (CZS) is challenging, mostly, when there is a transport problem, low access to information and a long distance between the house and health services. Participation can be understood as involvement in a life situation and is strongly influenced by physical ...
Coelho MLG +7 more
europepmc +2 more sources
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action Canabidiol: de um canabinóide inativo a uma droga com amplo espectro de ação [PDF]
Brazilian Journal of Psychiatry, 2008 OBJECTIVE: The aim of this review is to describe the historical development of research on cannabidiol. METHOD: This review was carried out on reports drawn from Medline, Web of Science and SciELO.
Antonio Waldo Zuardi
doaj +4 more sources
O uso de canabidiol (CBD) em pacientes pediátricos com transtorno do espectro autista [PDF]
Revista Pró-UniverSUS, 2022 O uso de Canabidiol (CBD) para aplicações clínicas tem ganhado atenção crescente devido à falta de propriedades psicoativas e benefícios potenciais que foram observados em certos estados de doença, como epilepsia pediátrica.
Gustavo Augusto Ramos da Cunha +5 more
doaj +3 more sources
Perfil antipsicótico do canabidiol
Medicina, 2014 O canabidiol, fitocanabinóide presente na planta Cannabis sativa é desprovido dos efeitos psicotomiméticos característicos do principal composto da Cannabis, o ∆9-tetraidrocanabinol, mais conhecido como delta 9-THC.
João Francisco Cordeiro Pedrazzi +3 more
doaj +3 more sources
Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop. [PDF]
Epilepsia Open, 2021 Abstract Febrile infection‐related epilepsy syndrome (FIRES) is a rare catastrophic epileptic encephalopathy that presents suddenly in otherwise normal children and young adults causing significant neurological disability, chronic epilepsy, and high rates of mortality.
Koh S +20 more
europepmc +2 more sources
Avaliação do papel do sistema canabidiol em um modelo de lesão renal por isquemia/reperfusão em animais [PDF]
Revista Brasileira de Terapia Intensiva, 2015 RESUMO Objetivo: Investigar os efeitos da administração de canabidiol em um modelo de isquemia/reperfusão renal em animais. Métodos: Foi induzida uma lesão renal, por meio de 45 minutos de isquemia renal seguida por reperfusão.
Rodrigo Zon Soares +7 more
doaj +2 more sources
Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome. [PDF]
J Cell Mol Med, 2020 Abstract Considering lack of target‐specific antiviral treatment and vaccination for COVID‐19, it is absolutely exigent to have an effective therapeutic modality to reduce hospitalization and mortality rate as well as to improve COVID‐19‐infected patient outcomes. In a follow‐up study to our recent findings indicating the potential of Cannabidiol (CBD)
Salles ÉL +9 more
europepmc +2 more sources
The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis. [PDF]
Vet Dermatol, 2022 Background– Cannabidiol (CBD) and cannabidiolic acid (CBDA) are reported to have antinociceptive, immunomodulatory and anti‐inflammatory actions. Objectives – To determine if CBD/CBDA is an effective therapy for canine atopic dermatitis (cAD). Conclusions and clinical relevance – Cannabidiol/CBDA as an adjunct therapy decreased pruritus, and not skin ...
Loewinger M +4 more
europepmc +2 more sources